Repligen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.About RGEN
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America.
CEOOlivier Dominique Loeillot
CEOOlivier Dominique Loeillot
Employees1,778
Employees1,778
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded1981
Founded1981
Employees1,778
Employees1,778
RGEN Key Statistics
Market cap9.12B
Market cap9.12B
Price-Earnings ratio6.29K
Price-Earnings ratio6.29K
Dividend yield—
Dividend yield—
Average volume699.59K
Average volume699.59K
High today$165.30
High today$165.30
Low today$160.49
Low today$160.49
Open price$162.29
Open price$162.29
Volume610.07K
Volume610.07K
52 Week high$182.52
52 Week high$182.52
52 Week low$102.97
52 Week low$102.97
Stock Snapshot
As of today, Repligen(RGEN) shares are valued at $162.02. The company's market cap stands at 9.12B, with a P/E ratio of 6291.44.
As of 2026-01-17, Repligen(RGEN) stock has fluctuated between $160.49 and $165.30. The current price stands at $162.02, placing the stock +1.0% above today's low and -2.0% off the high.
The Repligen(RGEN)'s current trading volume is 610.07K, compared to an average daily volume of 699.59K.
In the last year, Repligen(RGEN) shares hit a 52-week high of $182.52 and a 52-week low of $102.97.
In the last year, Repligen(RGEN) shares hit a 52-week high of $182.52 and a 52-week low of $102.97.
Analyst ratings
74%
of 23 ratingsBuy
73.9%
Hold
26.1%
Sell
0%
People also own
Based on the portfolios of people who own RGEN. This list is generated using Robinhood data, and it’s not a recommendation.